Johnson & Johnson became the latest major firm to partner with Enlight Biosciences, joining the ranks of Eli Lilly and Co., Merck & Co. and Pfizer. Enlight strives to find technology in areas such as molecular imaging that could help in drug discovery and development. A J&J official said the project will help the drugmaker "identify technology needs and influence future industry standards."

Full Story:

Related Summaries